![NUE](https://knoxdaily.com/wp-content/uploads/2020/09/pexels-andrea-piacquadio-3823493.jpg)
Robert W. Baird’s latest rating for DNLI stock
In a filing, Denali Therapeutics Inc revealed its Chief Medical Officer Ho Carole unloaded Company’s shares for reported $0.25 million
In a filing, Denali Therapeutics Inc revealed its Chief Medical Officer Ho Carole unloaded Company’s shares for reported $0.25 million
Denali Therapeutics Inc’s filing revealed that its Chief Medical Officer Ho Carole unloaded Company’s shares for reported $0.25 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Denali Therapeutics
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Denali Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Ho Carole unloaded Company’s shares for reported $0.25 million
Denali Therapeutics Inc’s recent filing unveils that its Director SATO VICKI L unloaded Company’s shares for reported $64403.0 on Jan
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Denali Therapeutics Inc. (NASDAQ:DNLI) does about 640.18K shares in volume on a normal day but saw 472397 shares change hands
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.